- Home
- Publications
- Publication Search
- Publication Details
Title
ABCG2/BCRP: Specific and Nonspecific Modulators
Authors
Keywords
-
Journal
MEDICINAL RESEARCH REVIEWS
Volume 37, Issue 5, Pages 987-1050
Publisher
Wiley
Online
2016-12-24
DOI
10.1002/med.21428
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HIV-1 Alters Intestinal Expression of Drug Transporters and Metabolic Enzymes: Implications for Antiretroviral Drug Disposition
- (2016) Olena Kis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Role of ABCB1, ABCG2, ABCC2 and ABCC5 transporters in placental passage of zidovudine
- (2016) Zuzana Neumanova et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Flavonoid derivatives as selective ABCC1 modulators: Synthesis and functional characterization
- (2016) José Esteban Obreque-Balboa et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The combination of quinazoline and chalcone moieties leads to novel potent heterodimeric modulators of breast cancer resistance protein (BCRP/ABCG2)
- (2016) Stefanie Kraege et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and Investigation of Tetrahydro-β-carboline Derivatives as Inhibitors of the Breast Cancer Resistance Protein (ABCG2)
- (2016) Anna Spindler et al. JOURNAL OF MEDICINAL CHEMISTRY
- Feeling Nature’s PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS)
- (2016) Jonathan B. Baell JOURNAL OF NATURAL PRODUCTS
- Ferrocenyl 2,5-Piperazinediones as Tubulin-Binding Organometallic ABCB1 and ABCG2 Inhibitors Active against MDR Cells
- (2016) Anna Wieczorek et al. ACS Medicinal Chemistry Letters
- Design of inhibitors of BCRP/ABCG2
- (2015) Kapil Juvale et al. Future Medicinal Chemistry
- Can Invalid Bioactives Undermine Natural Product-Based Drug Discovery?
- (2015) Jonathan Bisson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Marine Natural Products as Breast Cancer Resistance Protein Inhibitors
- (2015) Lilia Cherigo et al. Marine Drugs
- Membrane Interactions of Phytochemicals as Their Molecular Mechanism Applicable to the Discovery of Drug Leads from Plants
- (2015) Hironori Tsuchiya MOLECULES
- Phytochemicals Perturb Membranes and Promiscuously Alter Protein Function
- (2014) Helgi I. Ingólfsson et al. ACS Chemical Biology
- Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivo
- (2014) Kamlesh Sodani et al. BIOCHEMICAL PHARMACOLOGY
- Discovery of alkoxyl biphenyl derivatives bearing dibenzo[c,e]azepine scaffold as potential dual inhibitors of P-glycoprotein and breast cancer resistance protein
- (2014) Xiaoke Gu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- AST1306, a potent EGFR inhibitor, antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance
- (2014) Hui Zhang et al. CANCER LETTERS
- Statins inhibit ABCB1 and ABCG2 drug transporter activity in chronic myeloid leukemia cells and potentiate antileukemic effects of imatinib
- (2014) Eliza Glodkowska-Mrowka et al. EXPERIMENTAL HEMATOLOGY
- Linsitinib (OSI-906) antagonizes ATP-binding cassette subfamily G member 2 and subfamily C member 10-mediated drug resistance
- (2014) Hui Zhang et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Multidrug Resistance Protein 1 (MRP1, ABCC1), a “Multitasking” ATP-binding Cassette (ABC) Transporter
- (2014) Susan P. C. Cole JOURNAL OF BIOLOGICAL CHEMISTRY
- ARRY-334543 Reverses Multidrug Resistance by Antagonizing the Activity of ATP-Binding Cassette Subfamily G Member 2
- (2014) De-Shen Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Converting Potent Indeno[1,2-b]indole Inhibitors of Protein Kinase CK2 into Selective Inhibitors of the Breast Cancer Resistance Protein ABCG2
- (2014) Gustavo Jabor Gozzi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Marine Natural Products with P-Glycoprotein Inhibitor Properties
- (2014) Dioxelis Lopez et al. Marine Drugs
- Emerging Strategies and Integrated Systems Microbiology Technologies for Biodiscovery of Marine Bioactive Compounds
- (2014) Javier Rocha-Martin et al. Marine Drugs
- Lamellarin O, a Pyrrole Alkaloid from an Australian Marine Sponge, Ianthella sp., Reverses BCRP Mediated Drug Resistance in Cancer Cells
- (2014) Xiao-Cong Huang et al. Marine Drugs
- Hop-derived prenylflavonoids are substrates and inhibitors of the efflux transporter breast cancer resistance protein (BCRP/ABCG2)
- (2014) Kee W. Tan et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Chemistry: Chemical con artists foil drug discovery
- (2014) Jonathan Baell et al. NATURE
- Potential modulation on BCRP and MRP 4 by onion: in vivo and ex-vivo studies
- (2014) Yu-Chin Lin et al. Journal of Functional Foods
- Cannabidiol enhances xenobiotic permeability through the human placental barrier by direct inhibition of breast cancer resistance protein: an ex vivo study
- (2013) Valeria Feinshtein et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Investigation of quinazolines as inhibitors of breast cancer resistance protein (ABCG2)
- (2013) Kapil Juvale et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Quinoline Carboxamide-Type ABCG2 Modulators: Indole and Quinoline Moieties as Anilide Replacements
- (2013) Stefanie Bauer et al. ChemMedChem
- Synthesis and biological evaluation of flavones and benzoflavones as inhibitors of BCRP/ABCG2
- (2013) Kapil Juvale et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Tandutinib (MLN518/CT53518) targeted to stem-like cells by inhibiting the function of ATP-binding cassette subfamily G member 2
- (2013) Xiao-qin Zhao et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Dietary polyacetylenes of the falcarinol type are inhibitors of breast cancer resistance protein (BCRP/ABCG2)
- (2013) Kee W. Tan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- ABCG2: recent discovery of potent and highly selective inhibitors
- (2013) Florine Lecerf-Schmidt et al. Future Medicinal Chemistry
- Increased oral availability and brain accumulation of the ALK inhibitor crizotinib by coadministration of the P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridar
- (2013) Seng Chuan Tang et al. INTERNATIONAL JOURNAL OF CANCER
- Structure–Activity Relationships of Chromone Derivatives toward the Mechanism of Interaction with and Inhibition of Breast Cancer Resistance Protein ABCG2
- (2013) Evelyn Winter et al. JOURNAL OF MEDICINAL CHEMISTRY
- Sorafenib Overcomes Irinotecan Resistance in Colorectal Cancer by Inhibiting the ABCG2 Drug-Efflux Pump
- (2013) T. Mazard et al. MOLECULAR CANCER THERAPEUTICS
- The FLT3 Inhibitor Quizartinib Inhibits ABCG2 at Pharmacologically Relevant Concentrations, with Implications for Both Chemosensitization and Adverse Drug Interactions
- (2013) Jasjeet Bhullar et al. PLoS One
- Benzanilide–Biphenyl Replacement: A Bioisosteric Approach to Quinoline Carboxamide-Type ABCG2 Modulators
- (2013) Cristian Ochoa-Puentes et al. ACS Medicinal Chemistry Letters
- Recent Advances in the Development of P-gp Inhibitors
- (2012) Christiane Baumert et al. Anti-Cancer Agents in Medicinal Chemistry
- The Anthelmintic Triclabendazole and Its Metabolites Inhibit the Membrane Transporter ABCG2/BCRP
- (2012) Borja Barrera et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Interaction of the EGFR inhibitors gefitinib, vandetanib, pelitinib and neratinib with the ABCG2 multidrug transporter: Implications for the emergence and reversal of cancer drug resistance
- (2012) Csilla Hegedüs et al. BIOCHEMICAL PHARMACOLOGY
- OSI-930 analogues as novel reversal agents for ABCG2-mediated multidrug resistance
- (2012) Ye-Hong Kuang et al. BIOCHEMICAL PHARMACOLOGY
- GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2- and ABCB1-mediated drug resistance
- (2012) Kamlesh Sodani et al. BIOCHEMICAL PHARMACOLOGY
- The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanisms
- (2012) Karthika Natarajan et al. BIOCHEMICAL PHARMACOLOGY
- Synthesis and biological evaluation of bifendate–chalcone hybrids as a new class of potential P-glycoprotein inhibitors
- (2012) Xiaoke Gu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- 4-Substituted-2-phenylquinazolines as inhibitors of BCRP
- (2012) Kapil Juvale et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Abstract 1746: Modulation of ABCG2 mediated multidrug resistance by xanthine derivatives
- (2012) Rui Ding et al. CANCER RESEARCH
- Localization of breast cancer resistance protein (Bcrp) in endocrine organs and inhibition of its transport activity by steroid hormones
- (2012) Anita C. A. Dankers et al. CELL AND TISSUE RESEARCH
- Tyrosine Kinase Inhibitors Influence ABCG2 Expression in EGFR-Positive MDCK BCRP Cells via the PI3K/Akt Signaling Pathway
- (2012) Anne Pick et al. ChemMedChem
- Recent Advances in the Medicinal Chemistry of Aurones
- (2012) R. Haudecoeur et al. CURRENT MEDICINAL CHEMISTRY
- Synthesis of methylated quercetin derivatives and their reversal activities on P-gp- and BCRP-mediated multidrug resistance tumour cells
- (2012) Jian Yuan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and biological evaluation of novel bifendate derivatives bearing 6,7-dihydro-dibenzo[c,e]azepine scaffold as potent P-glycoprotein inhibitors
- (2012) Xiaoke Gu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Identification of novel dietary phytochemicals inhibiting the efflux transporter breast cancer resistance protein (BCRP/ABCG2)
- (2012) Kee W. Tan et al. FOOD CHEMISTRY
- A template model for studying anticancer drug efflux transporter inhibitorsin vitro
- (2012) Alexandre Sostelly et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Investigation of Chalcones as Selective Inhibitors of the Breast Cancer Resistance Protein: Critical Role of Methoxylation in both Inhibition Potency and Cytotoxicity
- (2012) Glaucio Valdameri et al. JOURNAL OF MEDICINAL CHEMISTRY
- Asperjinone, a Nor-Neolignan, and Terrein, a Suppressor of ABCG2-Expressing Breast Cancer Cells, from Thermophilic Aspergillus terreus
- (2012) Wen-Ying Liao et al. JOURNAL OF NATURAL PRODUCTS
- The Novel BCR-ABL and FLT3 Inhibitor Ponatinib Is a Potent Inhibitor of the MDR-Associated ATP-Binding Cassette Transporter ABCG2
- (2012) R. Sen et al. MOLECULAR CANCER THERAPEUTICS
- New Use for an Old Drug: Inhibiting ABCG2 with Sorafenib
- (2012) Y. Wei et al. MOLECULAR CANCER THERAPEUTICS
- Oral Availability and Brain Penetration of the B-RAFV600E Inhibitor Vemurafenib Can Be Enhanced by the P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) Inhibitor Elacridar
- (2012) Selvi Durmus et al. MOLECULAR PHARMACEUTICS
- Enhancing Chemosensitivity in ABCB1- and ABCG2-Overexpressing Cells and Cancer Stem-like Cells by An Aurora Kinase Inhibitor CCT129202
- (2012) Chao Cheng et al. MOLECULAR PHARMACEUTICS
- Cadmium inhibits ABCG2 transporter function in BeWo choriocarcinoma cells and MCF-7 cells overexpressing ABCG2
- (2012) M. Kummu et al. PLACENTA
- Methoxy Stilbenes as Potent, Specific, Untransported, and Noncytotoxic Inhibitors of Breast Cancer Resistance Protein
- (2011) Glaucio Valdameri et al. ACS Chemical Biology
- Efavirenz is a substrate and in turn modulates the expression of the efflux transporter ABCG2/BCRP in the gastrointestinal tract of the rat
- (2011) Roxana N. Peroni et al. BIOCHEMICAL PHARMACOLOGY
- Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance protein
- (2011) Kapil Juvale et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Solid phase synthesis of tariquidar-related modulators of ABC transporters preferring breast cancer resistance protein (ABCG2)
- (2011) Cristian Ochoa Puentes et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Sildenafil Reverses ABCB1- and ABCG2-Mediated Chemotherapeutic Drug Resistance
- (2011) Z. Shi et al. CANCER RESEARCH
- Aurones as Modulators of ABCG2 and ABCB1: Synthesis and Structure-Activity Relationships
- (2011) Hong May Sim et al. ChemMedChem
- Improving Cancer Chemotherapy with Modulators of ABC Drug Transporters
- (2011) S. Shukla et al. CURRENT DRUG TARGETS
- The Challenge of Exploiting ABCG2 in the Clinic
- (2011) Robert W. Robey et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Differential Impact of P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) on Axitinib Brain Accumulation and Oral Plasma Pharmacokinetics
- (2011) B. Poller et al. DRUG METABOLISM AND DISPOSITION
- The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan
- (2011) O. Arnaud et al. EUROPEAN JOURNAL OF CANCER
- Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration
- (2011) Seng Chuan Tang et al. INTERNATIONAL JOURNAL OF CANCER
- Substituted Chromones as Highly Potent Nontoxic Inhibitors, Specific for the Breast Cancer Resistance Protein
- (2011) Glaucio Valdameri et al. JOURNAL OF MEDICINAL CHEMISTRY
- Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression
- (2011) Stefania Nobili et al. MEDICINAL RESEARCH REVIEWS
- Novel Acrylonitrile Derivatives, YHO-13177 and YHO-13351, Reverse BCRP/ABCG2-Mediated Drug Resistance In Vitro and In Vivo
- (2011) R. Yamazaki et al. MOLECULAR CANCER THERAPEUTICS
- Olomoucine II and purvalanol A inhibit ABCG2 transporter in vitro and in situ and synergistically potentiate cytostatic effect of mitoxantrone
- (2011) Jakub Hofman et al. PHARMACOLOGICAL RESEARCH
- The “Specific” P-Glycoprotein Inhibitor Tariquidar Is Also a Substrate and an Inhibitor for Breast Cancer Resistance Protein (BCRP/ABCG2)
- (2010) Pavitra Kannan et al. ACS Chemical Neuroscience
- Structure–activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP)
- (2010) Anne Pick et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and structure–activity relationship of botryllamides that block the ABCG2 multidrug transporter
- (2010) Kentaro Takada et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Inhibition of ABCG2-mediated drug efflux by naphthopyrones from marine crinoids
- (2010) Heidi R. Bokesch et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Structure and Function of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)
- (2010) Zhanglin Ni et al. CURRENT DRUG METABOLISM
- Differential interactions between statins and P-glycoprotein: Implications for exploiting statins as anticancer agents
- (2010) Carolyn A. Goard et al. INTERNATIONAL JOURNAL OF CANCER
- 17-β-Estradiol: A Powerful Modulator of Blood–Brain Barrier BCRP Activity
- (2010) Anika MS Hartz et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Total Synthesis of Natural and Non-Natural Δ5,6Δ12,13-Jatrophane Diterpenes and Their Evaluation as MDR Modulators
- (2010) Christoph Schnabel et al. JOURNAL OF ORGANIC CHEMISTRY
- The Role of the Breast Cancer Resistance Protein (ABCG2) in the Distribution of Sorafenib to the Brain
- (2010) S. Agarwal et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Jatropha Diterpenes: a Review
- (2010) Rakshit K. Devappa et al. JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY
- BCRP at the Blood−Brain Barrier: Genomic Regulation by 17β-Estradiol
- (2010) Anne Mahringer et al. MOLECULAR PHARMACEUTICS
- Botryllamides: Natural Product Inhibitors of ABCG2
- (2009) Curtis J. Henrich et al. ACS Chemical Biology
- Nilotinib (AMN107, Tasigna ® ) reverses multidrug resistance by inhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR transporters
- (2009) Amit K. Tiwari et al. BIOCHEMICAL PHARMACOLOGY
- Novel lead for potent inhibitors of breast cancer resistance protein (BCRP)
- (2009) Anne Pick et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A novel chalcone derivative which acts as a microtubule depolymerising agent and an inhibitor of P-gp and BCRP in in-vitro and in-vivoglioblastoma models
- (2009) Ahcene Boumendjel et al. BMC CANCER
- Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2
- (2009) Chun-ling Dai et al. CANCER LETTERS
- Dofequidar fumarate sensitizes cancer stem-like side population cells to chemotherapeutic drugs by inhibiting ABCG2/BCRP-mediated drug export
- (2009) Ryohei Katayama et al. CANCER SCIENCE
- Multi-Drug-Resistance-Reverting Agents: 2-Aryloxazole and 2-Arylthiazole Derivatives as Potent BCRP or MRP1 Inhibitors
- (2009) Nicola A. Colabufo et al. ChemMedChem
- Brain Accumulation of Dasatinib Is Restricted by P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) and Can Be Enhanced by Elacridar Treatment
- (2009) J. S. Lagas et al. CLINICAL CANCER RESEARCH
- Potential of Flavonoids as Anti-inflammatory Agents: Modulation of Pro- Inflammatory Gene Expression and Signal Transduction Pathways
- (2009) M. Tunon et al. CURRENT DRUG METABOLISM
- The Effect of Breast Cancer Resistance Protein and P-Glycoprotein on the Brain Penetration of Flavopiridol, Imatinib Mesylate (Gleevec), Prazosin, and 2-Methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic Acid (PF-407288) in Mice
- (2009) L. Zhou et al. DRUG METABOLISM AND DISPOSITION
- Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)
- (2009) Nicolas Tournier et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Potent and Selective Inhibitors of Breast Cancer Resistance Protein (ABCG2) Derived from thep-Glycoprotein (ABCB1) Modulator Tariquidar
- (2009) Matthias Kühnle et al. JOURNAL OF MEDICINAL CHEMISTRY
- ABC Transporters as Potential Targets for Modulation of Drug Resistance
- (2009) L. Gatti et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- The beta-carboline alkaloid harmine inhibits BCRP and can reverse resistance to the anticancer drugs mitoxantrone and camptothecin in breast cancer cells
- (2009) Yonggang Ma et al. PHYTOTHERAPY RESEARCH
- Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy
- (2008) Kohji Noguchi et al. ADVANCED DRUG DELIVERY REVIEWS
- ABCG2: A perspective
- (2008) Robert W. Robey et al. ADVANCED DRUG DELIVERY REVIEWS
- Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478
- (2008) Zhi Shi et al. BIOCHEMICAL PHARMACOLOGY
- Synthesis and structure–activity relationship studies on tryprostatin A, an inhibitor of breast cancer resistance protein
- (2008) Hiteshkumar D. Jain et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Structure–activity relationships of new inhibitors of breast cancer resistance protein (ABCG2)
- (2008) Anne Pick et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2
- (2008) C.-l. Dai et al. CANCER RESEARCH
- Dimethoxyaurones: Potent inhibitors of ABCG2 (breast cancer resistance protein)
- (2008) Hong-May Sim et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Modulation of breast cancer resistance protein (BCRP/ABCG2) by non-basic chalcone analogues
- (2008) Yi Han et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- In silicoprediction of substrate properties for ABC-multidrug transporters
- (2008) Michael A Demel et al. Expert Opinion on Drug Metabolism & Toxicology
- Acridine/acridone: a simple scaffold with a wide range of application in oncology
- (2008) Philippe Belmont et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Discovery of a new series of jatrophane and lathyrane diterpenes as potent and specific P-glycoprotein modulators
- (2008) Elisa Barile et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Cellular Phototoxicity Evoked Through the Inhibition of Human ABC Transporter ABCG2 by Cyclin-dependent Kinase Inhibitors In vitro
- (2008) Ran An et al. PHARMACEUTICAL RESEARCH
- Curcumin Inhibits the Activity of ABCG2/BCRP1, a Multidrug Resistance-Linked ABC Drug Transporter in Mice
- (2008) Suneet Shukla et al. PHARMACEUTICAL RESEARCH
- Aurora Kinase Family: A New Target for Anticancer Drug
- (2008) Teresa Macarulla et al. Recent Patents on Anti-Cancer Drug Discovery
- Synthesis of potent BCRP inhibitor—Ko143
- (2008) Yuexian Li et al. TETRAHEDRON LETTERS
- Functionalized chalcones as selective inhibitors of P-glycoprotein and breast cancer resistance protein
- (2007) Xiao-Ling Liu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids
- (2007) M L Holland et al. BRITISH JOURNAL OF PHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started